IMMU-28. DEFINING MOLECULAR MECHANISMS OF RESISTANCE TO GLIOBLASTOMA (GBM) IMMUNITY USING A NOVEL CRISPR/CAS9 IN VIVO LOSS-OF-FUNCTION SCREENING PLATFORM
IMMU-28. 利用新型 CRISPR/Cas9 体内功能缺失筛选平台定义胶质母细胞瘤 (GBM) 免疫耐药的分子机制
期刊:Immunological Reviews
影响因子:8.3
doi:10.1111/j.1600-065X.2009.00816.x
Cahalan, Michael D; Chandy, K George; Zhang, Tiantian; Wang, Zhe; Cha, Soung-Chul; Liu, Jingwei; Dong, Zhenyuan; Szymura, Szymon; Anderson, Aaron; Kuang, Benjamin; Neelapu, Sattva; Kwak, Larry; Neagu, Martha R; Speranza, Maria Carmela; Manguso, Robert T; Lawler, Sean E; Freeman, Gordon J; Doench, John; Sharpe, Arlene H; Haining, W Nicholas